Evaluation of cardiac abnormalities by Doppler echocardiography in a large nationwide multicentric cohort of patients with systemic sclerosis

Annals of the Rheumatic Diseases

Volumn 67, Issue 1, 2008, Pages 31-36

  De Groote, Pascal ^a   Gressin, V ^b   Hachulla, E ^a   Carpentier, P ^c   Guillevin, L ^d   Kahan, A ^d   Cabane, J ^e   Frances C ^f   Lamblin, N ^a   Diot, E ^g   Patat, F ^g   Sibilia, J ^h   Petit, H ^h   Cracowski, J L ^c   Clerson, P ⁱ   Humbert, M ^j  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b Actelion Pharmaceuticals France   (France)

^c GRENOBLE UNIVERSITY HOSPITAL   (France)

^d Hôpital Nord ^*  (France)

^e HÔPITAL SAINT ANTOINE   (France)

^f PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^g UNIVERSITY HOSPITAL OF TOURS   (France)

^h UNIVERSITY HOSPITAL OF STRASBOURG   (France)

ⁱ Orgametrie   (France)

^j HÔPITAL ANTOINE BÉCLÈRE   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD PRESSURE; CARDIOLOGIST; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC DYSFUNCTION; DISEASE SEVERITY; DOPPLER ECHOCARDIOGRAPHY; EVALUATION; FEMALE; FOLLOW UP; FRANCE; HEART CATHETERIZATION; HEART DISEASE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE CONTRACTION; HEART VENTRICLE HYPERTROPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE; MULTICENTER STUDY; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PULMONARY HYPERTENSION; RANDOMIZED CONTROLLED TRIAL; SYSTEMIC SCLEROSIS; SYSTOLIC DYSFUNCTION;

EID: 37749044430     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2006.057760     Document Type: Article

References (35)

1. Ioannidis JP, Vlachoyiannopoulos PG, Haidich AB, Medsger TA Jr, Lucas M, Michet CJ, et al. Mortality in systemic sclerosis: an international meta-analysis of individual patient data. Am J Med 2005;118:2-10.
2. Steen VD, Medsger TA Jr. Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum 2000;43:2437- 44.
3. Hesselstrand R, Scheja A, Akesoon A. Mortality and causes of death in a Swedish series of systemic sclerosis patients. Ann Rheum Dis 1998;57:682-6.
4. Ferri C, Valentini G, Cozzi F, Sebastiani M, Michelassi C, La Montagna G, et al. Systemic Sclerosis Study Group of the Italian Society of Rheumatology. Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients. Medicine (Baltimore) 2002;81:139-53.
5. MacGregor AJ, Canavan R, Knight C, Denton CP, Davar J, Coghlan J, et al. Pulmonary hypertension in systemic sclerosis: risk factors for progression and conseguences for survival. Rheumatology 2001;40:453-9.
6. Steen V, Medsger TA, Jr. Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement. Arthritis Rheum 2003;48:516-22.
7. Koh ET, Lee P, Gladman DD, Abu-Shakra M. Pulmonary hypertension in systemic sclerosis: an analysis of 17 patients. Br J Rheumatol 1996;35:989-93.
8. Kawut SM, Taichman DB, Archer-Chicko CL, Palevsky HI, Kimmel SE. Hemodynamics and survival in patients with pulmonary arterial hypertension related to systemic sclerosis. Chest 2003;123:344-50.
9. British Cardiac Society. Guidelines and Medical Practice Committee recommendations on the management of pulmonary hypertension in clinical practice. Heart 2001;86(Suppl 1)11-13.
10. Murata I, Kihara H, Shinohara S, Ito K. Echocardiographic evaluation of pulmonary arterial hypertension in patients with progressive systemic sclerosis and related syndromes. Jpn Circ J 1992;56:983- 91.
11. Battle RW, Davitt MA, Cooper SM, Buckley LM, Leib ES, Begun PA, et al. Prevalence of pulmonary hypertension in limited and diffuse scleroderma. Chest 1996;110:1515-19.
12. Launay D, Hachulla E, Hatron PY, Michon-Pasturel U, Hebbar M, Queyrel V, et al. Dépistage de l'hypertension artérielle pulmonaire au cours de la sclérodermie systémique: étude d'une cohorte de 67 patients. Rev Med Interne 2001;22:819-29.
13. Hachulla E, Gressin V, Guillevin L, Carpentier P, Diot E, Sibilia J, et al. Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study. Arthritis Rheum 2005;52:3792-800.
14. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988;1:202-5.
15. LeRoy EC, Medsger TA Jr. Criteria for the classification of early systemic sclerosis. J Rheumatol 2001;28:1573-6.
16. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantification of the left ventricle by two-dimensional echocardiography: American Society of Echocardiography Committee on Standards. Subcommittee on Quantification of two-dimensional echocardiograms. J Am Soc Echocardiogr 1989;2:358-67.
17. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, et al. Echocardiographic assessment of left ventricular hypertrophy, comparison to necropsy findings. Am J Cardiol 1986;57:450-8.
18. Oh JK, Seward JB, Tajik AJ. Assessment of diastolic function. In: Oh JK, Seward JB, Tajik AJ, eds. The echo manual. 2nd edn. Philadelpha, Pennsylvania: Lippincot-Raven, 1999:45-57.
19. Giannuzzi P, Temporelli PL, Bosimini E, Silva P, Imparato A, Corrà U, et al. Independent and incremental prognostic value of Doppler-derived mitral deceleration time of early filling in both symptomatic and asymptomatic patients with left ventricular dysfunction. J Am Coll Cardiol 1996;28:383-90.
20. Hansen A, Haass M, Zugck C, Krueger C, Unnebrink K, Zimmermann R, et al. Prognostic value of Doppler echocardiographic mitral inflow patterns: implications for risk stratification in patients with chronic congestive heart failure. J Am Coll Cardiol 2001;37:1049-55.
21. Le Guern V, Mahr A, Mouthon L, Jeanneret D, Carzon M, Guillevin L. Prevalence of scleroderma in a French multiethnic county. Rheumatology 2004;43:1129-37.
22. Borgeson DD, Seward JB, Miller FA Jr, Oh JK, Tajik AJ. Frequency of Doppler measurable pulmonary artery pressures. J Am Soc Echocardiogr 1996;9:832-7.
23. Mukerjee D, St George D, Coleiro B, Knight C, Denton CP, Davar J, et al. Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach. Ann Rheum Dis 2003;62:1088-93.
24. Barst RJ, McGoon M, Torbicki A, Sitbon O, Krowka MJ, Olschewski H, et al. Diagnosis and differential assessment of pulmonary arterial hypertension. J Am Coll Cardiol 2004;43(Suppl):40-7.
25. Fernandos F, Ramires FJ, Arteaga E, Ianni BM, Bonfa ES, Mady C. Cardiac remodeling in patients with systemic sclerosis with no signs or symptoms of heart failure: an endomyocardial biopsy study. J Card Fail 2003;9:311-17.
26. Valentini G, Vitale DF, Giunta A, Maione S, Gerundo G, Arnesse M, et al. Diastolic abnormalities in systemic sclerosis: evidence for associated defective cardiac functional reserve. Ann Rheum Dis 1996;55:455-60.
27. Candell-Riera J, Armadans-Gil L, Simeon CP, Castell-Conesa J, Fonollosa-Pla V, Garcia-del-Castillo H, et al. Comprehensive non-invasive assessment of cardiac involvement in limited systemic sclerosis. Arthritis Rheum 1996;39:1138-45.
28. Giunta A, Tirri E, Maione S, Cangianiello S, Mele A, De Luca A, et al. Right ventricular diastolic abnormalities in systemic sclerosis. Relation to left ventricular involvement and pulmonary hypertension. Ann Rheum Dis 2000;59:94-8.
29. Armstrong GP, Whalley GA, Doughty RN, Gamble GD, Flett SM, Tan PL, et al. Left ventricular function in scleroderma. Br J Rheumatol 1996;35:983-8.
30. Maione S, Cuomo G, Giunta A, Tanturri de Horation L, La Montagna G, Manguso F, et al. Echocardiographic alterations in systemic sclerosis: a longitudinal study. Semin Arthritis Rheum 2005;34:721-7.
31. Aguglia G, Sgreccia A, Bernardo ML, Carmenini E, Giusti De Marie M Reali A, et al. Left ventricular diastolic function in systemic sclerosis. J Rheumatol 2001;28:1563-7.
32. Fisher MR, Mathai SC, Champion HC, Girgis RE, Housten-Harris T, Hummers L, et al. Clinical differences between idiopathic and scleroderma-related pulmonary hypertension. Arthritis Rheum 2006;54:3043-50.
33. Meune C, Allanore Y, Devaux JY, Ekindjian OG, Kahan A. High prevalence of right ventricular systolic dysfunction in early systemic sclerosis. J Rheumatol 2004;31:1941-5.
34. Meune C, Allanore Y, Pascal O, Devaux JY, Dessault O, Duboc D, et al. Myocardial contractility is early affected in systemic sclerosis: a tissue Doppler echocardiography study. Eur J Echocardiogr 2005;6:351-7.
35. Vignaux O, Allanore Y, Meune C, Pascal O, Duboc D, Weber S, et al. Evaluation of the effect of nifedipine upon myocardial perfusion and contractility using cardiac magnetic resonance imaging and tissue Doppler echocardiography in systemic sclerosis; Ann Rheum Dis 2005;64:1268-73.